BDTX
Black Diamond Therapeutics
$1.83
+$0.08 (+4.57%)Oct 28, 2026
Key metrics
The numbers that frame BDTX today
- Market cap
- $105.14M
- ROIC
- -37.8%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $1.60
- 52wk High
- $4.94
Growth
Revenue and earnings trend for BDTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BDTX
Is Black Diamond Therapeutics a good buy?
No. Black Diamond Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Black Diamond Therapeutics is selling at a very high price.
What is the market capitalization of BDTX?
Black Diamond Therapeutics's market capitalization is $105.14M.
What is the 52-week high for BDTX stock?
The 52-week high for Black Diamond Therapeutics is $4.94. The current close of $1.83 is 63% below that high.
What is the 52-week low for BDTX stock?
The 52-week low for Black Diamond Therapeutics is $1.60. The current close of $1.83 is 14.4% above that low.
Does BDTX stock pay dividends?
Black Diamond Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BDTX?
Black Diamond Therapeutics's Debt / Equity ratio is 0.14.